YPOG advised Aignostics on the deal. Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and...
YPOG advised Aignostics on the deal. Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and...
You must be a Standard 1 Year member to access this content.